Search results for: 'sterilization forecast to 2026'

Consumables and services will lead the global demand for sterilization devices because sterilization capital equipment growth is becoming saturated in developed economies. In developing economies, the growing number of healthcare facilities and the focus on reducing infections will boost the uptake of sterilization capital equipment, and consumable...

30 Nov 2016  |  North America  |  Market Research

Third Party Sterilization Services for Care Providers in the US and Western Europe, Forecast to 2022

Hospitals are Increasingly Outsourcing their Surgical Instrument Sterilization - Next Frontier for Disinfection and Sterilization Equipment OEM?

Infographics

×

The study covers current and future market trends, drivers, and challenges in outsourcing of hospital sterile processing departments (SPD)/central sterile supply departments (CSSD) to specialized third party vendors. Despite being in the nascent phase, the third party sterilization services market generated total revenue of $1.4 billion in 2015 and...

08 Jun 2022  |  North America  |  Market Research

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...

The global distribution infrastructure and delivery market is entering a state of hyper-transformation in 2026. This market, which serves as the foundational architecture for the digital economy, has moved beyond the simple, high-speed movement of packets to become the primary orchestrator of digital trust, sovereign data residency, and autonomous ...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

The global enterprise landscape is currently navigating a profound era of transformation driven by the Intelligence Revolution. This shift is redefining the fundamental mechanics of how organizations create, manage, and orchestrate content at scale. In 2026, the digital content creation, management, and orchestration sector is moving beyond the sim...

This report provides a definitive strategic roadmap for the digital marketing and advertising technology (AdTech/MarTech) sector as it enters a transformative era in 2026. Moving beyond incremental updates, the industry is undergoing a fundamental architectural restructuring—shifting from a landscape of fragmented point solutions to one of unified ...

Global economic conditions in Q2 2026 are defined by heightened geopolitical stress, energy market volatility, and supply chain and trade disruptions. The outbreak of the US–Iran conflict has altered the global growth trajectory, trimming roughly 0.3 percentage points from annual expansion (compared to 3.4% in 2025) and pushing Q2 2026 growth to it...

This research service considers products and companies in the sterilization equipment and sterilants market in the United States. The market will benefit from many technology improvements going forward. A thorough analysis of revenue forecasts, unit forecasts, technological advances, and pricing are provided for the markets various segments, inclu...